crystalline compound, pharmaceutical composition, use of crystalline compound, crystalline vortioxetine hydrobromide hydrate, method for preparation of crystalline vortioxetine hydrobromide hydrate, method for preparation of crystalline compound and use of crystalline vortioxetine hydrobromide hydrate

摘要

abstract new crystalline form of vortioxetine hydrobromide The present invention relates to a crystalline compound comprising a hydrobromic acid (hbr) salt of a compound of formula i (1- {2 - [(2,4-dimethylphenyl) sulfanyl] phenyl} piperazine, inn: vortioxetine), with an xrpd pattern with characteristic peaks (expressed as 2 ± ± 0.2 ° 2 '(cuk? radiation)) at 5.5 °, 14.8 °, 16.7 ° and 20 ° , 0 °, and processes for obtaining the same. formula i